X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Cipla Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cipla Quarterly Results   (CIPL)

Here are the latest quarterly results of Cipla. For more details, see the Cipla financial fact sheet and Cipla share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Cipla Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m36,47235,82035,25140,82439,13836,98039,39040,119 
Other income Rs m1,5352281,5141,1335294001,7011,326 
Turnover Rs m38,00736,04836,76441,95739,66837,38041,09141,445 
Expenses Rs m29,69630,75828,78632,78030,95231,41132,12633,097 
Gross profit Rs m6,6675,0536,4658,0338,1784,7937,2537,022 
Depreciation Rs m2,5776,3222,1343,0225,2242,8482,4102,819 
Interest Rs m59333427942092352351444 
Profit before tax Rs m5,031-1,3755,5665,7243,3921,9936,1935,085 
Tax Rs m1,283-7571,3081,3746424621,7371,424 
Profit after tax Rs m3,748-6184,2584,3502,7501,5314,4563,661 
Gross profit margin %18.314.118.319.720.913.018.417.5 
Effective tax rate %25.555.123.524.018.923.228.028.0 
Net profit margin %10.3-1.712.110.77.04.111.39.1 
Diluted EPS Rs 4.7 -0.8 5.3 5.4 3.4 1.9 5.5 4.6  
Diluted EPS (TTM) Rs 14.6 12.8 13.6 14.6 13.4 16.0 16.3 15.4  
 Subscriber Feature View     View          
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Cipla 2QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  INDRAPRASTHA MEDICAL  DR. REDDYS LAB  

Compare CIPLA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  INDRAPRASTHA MEDICAL  DR. REDDYS LAB  

Compare CIPLA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 307 Points Higher; Metal and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets traded on a positive note throughout the day and ended on a strong note. Gains were seen in the metal sector.

Views on news

CIPLA Announces Quarterly Results (2QFY19); Net Profit Down 15.8% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, CIPLA has posted a net profit of Rs 4 bn (down 15.8% YoY). Sales on the other hand came in at Rs 40 bn (down 1.7% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (1QFY19); Net Profit Up 4.7% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, CIPLA has posted a net profit of Rs 4 bn (up 4.7% YoY). Sales on the other hand came in at Rs 39 bn (up 11.7% YoY). Read on for a complete analysis of CIPLA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

More Views on News

Most Popular

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Patel's Exit, Election Results, and 4 'Must Have' Small Caps in These Exceptional Times(Profit Hunter)

Dec 11, 2018

RBI Governor's resignation is a statement of dissent with the way government is handling the economy's affairs and could lead to some serious market correction. Here's how to make the most of it.

Players in an Oligopoly Should Have Financials Like This(Chart Of The Day)

Dec 7, 2018

This stock has corrected 30% from peak and looks attractive at these valuations.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Dec 17, 2018 (Close)

TRACK CIPLA

CIPLA - UNICHEM LAB COMPARISON

COMPARE CIPLA WITH

MARKET STATS